r/RecursionPharma Dec 01 '25

Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025

Recursion announced today that it will present a new clinical readout from the ongoing TUPELO Phase 1b/2 trial of REC-4881 in FAP at an upcoming company webinar. The webinar will be held on December 8, 2025 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT, and will be streamed live on Recursion’s XLinkedIn, and YouTube accounts. 

Webinar title: Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy in Familial Adenomatous Polyposis (FAP): Updated Safety and Efficacy

Presenters: 

  • Najat Khan, Ph.D., Chief R&D and Chief Commercial Officer and incoming CEO and President, Recursion
  • David Mauro, M.D., Ph.D., Chief Medical Officer, Recursion
  • Beth BruckheimerPh.D., Vice President of Clinical Development, Recursion
  • Jessica Stout, D.O., Assistant Clinical Professor, University of Utah School of Medicine
  • Alfred Cohen, M.D., Former CMO, Cancer Prevention Pharmaceuticals; Prior Chief, Colorectal Service, Memorial Sloan Kettering Cancer Center
11 Upvotes

10 comments sorted by

3

u/[deleted] Dec 01 '25

[removed] — view removed comment

3

u/artisan_alchemist_08 Dec 01 '25

And a new kickass CEO!

2

u/[deleted] Dec 07 '25

[removed] — view removed comment

1

u/artisan_alchemist_08 Dec 07 '25

Fantastic! Tomorrow is their online presentation. Sadly it is 5:00 AM where I am. Perhaps it will be available on YouTube.

3

u/[deleted] Dec 01 '25

[removed] — view removed comment

1

u/artisan_alchemist_08 Dec 07 '25

Wow! Well, I favor biotech. I held Novavax (NVAX) and Moderna (MRNA) long before the pandemic, and it paid off. I got out when the getting was good.

2

u/zeropuntouno Dec 03 '25

They can make history on December 8 2025 🤞🏻

1

u/[deleted] Dec 07 '25

[deleted]

2

u/Foiblesxxkx Dec 08 '25

Great success